GRANT AWARDS

Principal Investigator: Holley Allen
Project Name: A Phase 2/3, Randomized, Double-Blind, Multicenter, Multinational, 4-Arm, Controlled, Dose Ranging Study to Evaluate Efficacy and Safety of MGA031, a Humanized, FcR Non-Binding, Anti-CD-3 Monoclonal Antibody, in Children and Adults with Recent-Onset Type 1 Diabetes Mellitus
Sponsor: MacroGenics, Inc.

Principal Investigator: Holley Allen
Project Name: Randomized Controlled Trial Evaluating Response to a Combination of Metformin and Oral Contraceptive Pills versus Oral Contraceptive Pills Alone in the Treatment of Adolescents With Polycystic Ovarian Syndrome
Sponsor: Baystate Health, Inc.

Principal Investigator: Holley Allen
Project Name: Safety and Efficacy of Increlex
Sponsor: Tercica, Inc.

Principal Investigator: Richard Arenas
Project Name: A Prospective, Observational, Multicenter Study Assessing Early Postoperative Recovery Following Laparoscopic Partial Large Bowel Resection.
Sponsor: Adolor Corporation

Principal Investigator: Philip Day
Project Name: Acute Treatment Services: Level IIIA (RFR 404) Inpatient Detoxification Carlson House
Sponsor: Massachusetts Department of Public Health (DPH)

Principal Investigator: Philip Day
Project Name: Residential Recovery Services - My Sister's House [RFR 399]
Sponsor: Massachusetts Department of Public Health (DPH)

Principal Investigator: SatKiran Grewal
Project Name: Children's Oncology Group: Chairman's Grant
Sponsor: National Childhood Cancer Foundation

Principal Investigator: Gregory Giugliano
Project Name: A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multinational Clinical Trial to Evaluate the Efficacy of Aliskiren and Valsartan versus Placebo in Lowering Levels on NT-proBNP in Stabilized Patients Post-acute Coronary Syndromes "AVANT GARDE - TIMI 43"
Sponsor: Novartis Pharmaceuticals Corp.

Principal Investigator: John Landis
Project Name: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis "Pirfenidone"
Sponsor: Intermune, Inc.

Principal Investigator: Patrick Lee
Project Name: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when Administered as a 30 Minute i.v. Infusion for Postoperative Ileus to Subjects Undergoing Major Open Abdominal Surgery
Sponsor: Tranzyme, Inc.

Principal Investigator: Glenn Markenson
Project Name: Lipid Metabolism in Gestational Diabetics
Sponsor: BMC/UMASS Collaborative Research Program

Principal Investigator: Jay Steingrub
Project Name: Multi-marker Index for the Diagnosis of Sepsis in the Emergency Department (MINDSET)
Sponsor: Biosite Inc.

Principal Investigator: Chrystal Wittcopp
Project Name: Primary Prevention of Obesity in High Risk Preschoolers
Sponsor: Baystate Health, Inc.